Literature DB >> 2548545

The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice.

J Leonard1, J S Khillan, H E Gendelman, A Adachi, S Lorenzo, H Westphal, M A Martin, M S Meltzer.   

Abstract

Four lines of transgenic mice containing the HIV LTR linked to the bacterial gene encoding chloramphenicol acetyltransferase (CAT) were constructed. In each line, a characteristic tissue pattern of CAT expression was observed with detectable levels present in the eye, heart, spleen, thymus, and tail. Low levels of CAT were present in circulating lymphocytes, but CAT activity in these cells could be augmented following treatment with the mitogen phytohemagglutinin (PHA). Likewise, CAT expression was present at only low levels in circulating monocytes, but higher levels of CAT were observed in macrophages grown in the presence of various cytokines (CSF-1, GM-CSF, IL-1 alpha, IL-4, and IL-2). Furthermore, Langerhans cells recovered from skin showed higher levels of CAT activity than those observed in other cells of monocyte-macrophage lineage. These results indicate that LTR-CAT expression in cells of monocyte-macrophage lineage may increase in proportion to the degree of differentiation of these cells. These animals may be useful in the study of cell-specific determinants of LTR-directed gene activity and may serve to identify exogenous cofactors that promote the progression of HIV-related disease in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548545     DOI: 10.1089/aid.1989.5.421

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

1.  UV activation of human immunodeficiency virus gene expression in transgenic mice.

Authors:  J Vogel; M Cepeda; E Tschachler; L A Napolitano; G Jay
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 2.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.

Authors:  Yue Peng; Fan-ching Lin; Paulo H Verardi; Leslie A Jones; Tilahun D Yilma
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

4.  Expression of a human immunodeficiency virus type 1 long terminal repeat/simian virus 40 early region fusion gene in transgenic mice.

Authors:  J Skowronski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

5.  The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.

Authors:  P A Furth; L Hennighausen; C Baker; B Beatty; R Woychick
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

6.  Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection.

Authors:  S E Macatonia; M Gompels; A J Pinching; S Patterson; S C Knight
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

7.  Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.

Authors:  W Phares; W Herr
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Persistent infection of normal mice with human immunodeficiency virus.

Authors:  C Locardi; P Puddu; M Ferrantini; E Parlanti; P Sestili; F Varano; F Belardelli
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

Authors:  E Langhoff; E F Terwilliger; H J Bos; K H Kalland; M C Poznansky; O M Bacon; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.

Authors:  J D Morrey; S M Bourn; T D Bunch; M K Jackson; R W Sidwell; L R Barrows; R A Daynes; C A Rosen
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.